Rett Syndrome – Executive Insights – Rett Syndrome | Executive Insights | US/EU5

launch Related Market Assessment Reports

• Biomarkers In Oncology – Access & Reimbursement – Detailed, Expanded Analysis: Biomarkers In Oncology – Non-Small-Cell Lung Cancer, Breast Cancer, And Colorectal Cancer (US)

  September 2023

  Biomarker-driven prescribing is paramount in key oncology indications. The use of biomarkers is entrenched in non-small-cell lung cancer (NSCLC), breast cancer, and colorectal cancer. Biomarker-…

• Nonalcoholic Steatohepatitis – Current Treatment – Detailed, Expanded Analysis: Current Treatment: Physician Insights (US)

  September 2023

• Systemic Lupus Erythematosus – Landscape & Forecast – Disease Landscape & Forecast

  September 2023

  Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course, manifestations, and treatment approach can be…

• Amyotrophic Lateral Sclerosis – Landscape & Forecast – Disease Landscape & Forecast

  September 2023

  Amyotrophic lateral sclerosis (ALS) is a progressively debilitating disorder of the central nervous system characterized by motor neuron degeneration. ALS causes progressive weakness and atrophy of…

• Glaucoma – Unmet Need – Detailed, Expanded Analysis (US/EU)

  Glaucoma is a progressive disease of the optic nerve caused by high intraocular pressure (IOP); it is one of the leading causes of vision loss in the United States and Europe. The majority of…